Mattia Marchi, Pietro Grenzi, Antonio Travascio, Daniele Uberti, Edoardo De Micheli, Fabio Quartaroli, Giuseppe Laquatra, Luca Pingani, Silvia Ferrari, Gian M. Galeazzi
BJPsych Open, 2025-10-27
Background Withania somnifera (WS) is considered an adaptogen agent with reported antistress, cognition facilitating and anti-inflammatory properties, which may be…
Małgorzata Charmas, Ewa Jówko, Barbara Długołęcka, Andrzej Klusiewicz, Iwona Przybylska, Anna Galczak-Kondraciuk
Nutrients, 2025-10-16
Background/Objectives: High-intensity interval training (HIIT) is considered an effective way in improving aerobic capacity and selected health parameters. Ashwagandha is…
Mahavir Singh, Rakesh C. Kukreja, Darini Nagarajan, Sham S. Kakar
Journal of Ovarian Research, 2025-10-1
Cancer-induced cachexia is a multifactorial syndrome characterized by severe skeletal muscle and cardiac atrophy, contributing significantly to patient morbidity and…
International Journal of Pharmaceutical Investigation, 2025-10-01
Discover this 2025 paper in International Journal of Pharmaceutical Investigation by Rajendran; Raj, Sudesh; Tejas; et. al. focusing on: ANTIOXIDANTS;…
Nawab John Dar, Bisma Gull, Abid Hamid, Zabeer Ahmed, Muzamil Ahmad
Steroids, 2025-10-01
Withania somnifera, commonly known as Ashwagandha, is widely utilized for treating neurological disorders in both traditional and modern medicine. While…
Razan Fawaz Hasanyn, Ashwaq H. Batawi, Mona A. AL-Thepyani, Reham Tash, Asma Almuhammadi, Ashwaq Hassan Alsabban, Badrah S. Alghamdi
Cells, 2025-9-22
Fibromyalgia syndrome (FMS) is a chronic disorder marked by widespread musculoskeletal pain, fatigue, mood disturbances, and cognitive impairments. Current treatments…